Skip to main content
. 2016 Jan 25;71(6):526–534. doi: 10.1136/thoraxjnl-2014-206724

Table 1.

Baseline characteristics by % predicted FEV1 in 3242 men with no prior heart failure or myocardial infarction

  % predicted FEV1
≤5th percentile 6–24th percentile 25–49th percentile 50–74th percentile ≥75th percentile p Difference between groups
No. of men 162 651 810 813 806
Range FEV1, % predicted <48.4  48.4–75.0 75.1–89.0  89.1–101.6 ≥101.7
FEV (L) 1.12 (0.26) 1.92 (0.31) 2.49 (0.31) 2.86 (0.34) 3.33 (0.47)
FVC (L) 2.12 (0.09) 2.77 (0.06) 3.27 (0.06) 3.64 (0.06) 4.13 (0.07)
% FEV1/FVC<0.7 33.3 34.1 30.3 26.8 21.1
Categorical variables (%)
 Smokers 27.2 21.4 13.8 8.5 4.7 <0.001
 Manual 63.6 62.5 54.0 51.3 45.8 <0.001
 Inactive 54.4 39.0 31.6 30.8 26.2 <0.001
 Heavy drinkers  6.2 5.2 3.2 4.2 3.0 0.083
 Diabetes 14.8 16.0 12.4 10.8 10.4 0.001
 Stroke 6.8 5.5 5.1 2.8 3.4 0.017
 AF 3.7 3.5 3.5 2.8 2.4 0.620
 Antihypertensive use 33.3 34.1 30.3 26.8 21.1 <0.001
 Left ventricular hypertrophy 5.6 6.3 7.3 8.9 8.2 0.302
Continuous variables (means)
 Age (years) 69.4 (5.4) 69.1 (5.4) 68.0 (5.2) 67.8 (5.5) 68.9 (5.7) <0.001
 BMI (kg/m2) 25.5 (3.9) 27.1 (4.0) 27.1 (3.7) 26.9 (3.3) 26.4 (3.2) <0.001
 Systolic blood pressure (mm Hg) 147.8 (21.9) 151.5 (25.4) 149.2 (23.5) 150.8 (24.1) 148.7 (22.9) 0.090
 Cholesterol (mmol/L) 5.86 (1.10) 5.93 (1.02) 6.10 (1.10) 6.09 (1.04) 6.09 (1.06) 0.002
 High-density lipoprotein-cholesterol (mmol/L) 1.41 (0.41) 1.31 (0.35) 1.32 (0.34) 1.31 (0.33) 1.36 (0.33) 0.002
 C-reactive protein (mg/L)* 4.48 (1.30–6.01) 2.27 (1.08–4.82) 1.82 (0.90–3.47) 1.38 (0.73–2.87) 1.23 (0.60–2.40) <0.001
 N-terminal pro-brain natriuretic peptide (pg/mL)* 115.6 (55–257) 108.9 (49–220) 86.5 (44–160) 77.5 (38–147) 80.6 (41–146) <0.001
  Cardiac troponin T (pg/mL)* 13.7 (10.1–18.9) 12.4 (9.3–16.4) 11.2 (8.6–15.9) 11.0 (8.5–14.8) 11.0 (8.2–14.7) <0.001

Mean and SD unless specified.

*Geometric mean and IQR.